The serine kinases IKK2 and JNK1 contribute to insulin resistance by phosphorylation of IRS-1. This activity has been widely used to explain insulin resistance for many risk factors including inflammation, lipotoxicity, ER stress and oxidative stress. Our study in the last funding period suggests that S6K and HDACs are targeted by the two serine kinases in the regulation of glucose and lipid metabolism. Our data suggests that IKK2 and JNK1 signals may be integrated in the S6K1 activation in the cytoplasm for IRS-1 inhibition. Their signals may also be combined in the regulation of PPARg activity in the nucleus through HDACs. Based on these observations, we hypothesize that S6K1 and HDACs may mediate signals of IKK2 and JNK1 in the regulation of glucose and lipid metabolism. However, the hypothesis remains to be tested and the details remain to be uncovered. We will address these issues in two specific aims:
AIM I : To test that the IKK2-JNK1 signal integration may lead to S6K activation in the cytoplasm;
AIM II : To test that the IKK2-JNK1 signal integration may control HDACs function in the nucleus. The results will provide a novel and unified mechanism for IKK2 and JNK1 in the regulation of glucose and fatty acid metabolism. The study may lead to identification of new drug target in prevention and treatment of metabolic syndrome.

Public Health Relevance

Type 2 diabetes has been a major health threat to the general public in US. The treatment and prevention of the disease is limited by our understanding of the molecular mechanism of the diseases. In this study, we will investigate the molecular mechanism by focusing on two molecules IKK2 and JNK1. The study will help us to understand the molecular mechanisms, and to identify new drug target for type 2 diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK068036-08
Application #
8314036
Study Section
Cellular Aspects of Diabetes and Obesity Study Section (CADO)
Program Officer
Abraham, Kristin M
Project Start
2004-06-01
Project End
2014-08-31
Budget Start
2012-09-01
Budget End
2013-08-31
Support Year
8
Fiscal Year
2012
Total Cost
$304,029
Indirect Cost
$98,604
Name
Lsu Pennington Biomedical Research Center
Department
None
Type
Organized Research Units
DUNS #
611012324
City
Baton Rouge
State
LA
Country
United States
Zip Code
70808
Wang, Hui; Ye, Jianping (2015) Regulation of energy balance by inflammation: common theme in physiology and pathology. Rev Endocr Metab Disord 16:47-54
Cuadrado, Antonio; Martín-Moldes, Zaira; Ye, Jianping et al. (2014) Transcription factors NRF2 and NF-?B are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation. J Biol Chem 289:15244-58
Wang, Y; Wang, H; Hegde, V et al. (2013) Interplay of pro- and anti-inflammatory cytokines to determine lipid accretion in adipocytes. Int J Obes (Lond) 37:1490-8
Zhang, Jin; Gao, Zhanguo; Ye, Jianping (2013) Phosphorylation and degradation of S6K1 (p70S6K1) in response to persistent JNK1 Activation. Biochim Biophys Acta 1832:1980-8
Gao, Zhan-guo; Ye, Jian-ping (2012) Why do anti-inflammatory therapies fail to improve insulin sensitivity? Acta Pharmacol Sin 33:182-8
Tchoukalova, Yourka D; Fitch, Mark; Rogers, Pamela M et al. (2012) In vivo adipogenesis in rats measured by cell kinetics in adipocytes and plastic-adherent stroma-vascular cells in response to high-fat diet and thiazolidinedione. Diabetes 61:137-44
Li, Huating; Gao, Zhanguo; Zhang, Jin et al. (2012) Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3. Diabetes 61:797-806
He, Qing; Gao, Zhanguo; Yin, Jun et al. (2011) Regulation of HIF-1{alpha} activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab 300:E877-85
Krishnapuram, R; Dhurandhar, E J; Dubuisson, O et al. (2011) Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 300:E779-89
Xia, Xuan; Yan, Jinhua; Shen, Yunfeng et al. (2011) Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 6:e16556

Showing the most recent 10 out of 25 publications